Social Network Encouragement for Colon Cancer Screening
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to increase colorectal cancer screenings in the Black community by training participants to encourage others in their social circles to get tested. Participants will learn how to discuss FIT testing, a simple at-home test that checks for signs of cancer in stool, with friends and family. The study will compare two groups: one receiving general education about colorectal cancer and another receiving detailed support on promoting FIT testing through Peer Outreach, a social network intervention. It is suitable for Black men aged 45 to 75 who have completed FIT testing in the past year and have a network of at least five close Black male friends or relatives in the same age range. As an unphased trial, this study offers participants the opportunity to contribute to community health by promoting early cancer detection.
Do I have to stop taking my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this peer outreach program is safe for increasing colorectal cancer screening?
Research has shown that organized programs for colorectal cancer (CRC) screening are safe and effective. These programs help people, especially in underserved communities, overcome barriers to screening. For example, the SCORE project, which focused on CRC screening outreach, found that these programs can successfully address common obstacles without causing harm.
Studies have found that these outreach efforts are generally well-received. They provide education and support to encourage screening using the fecal immunochemical test (FIT). This test checks for signs of cancer in stool samples and can be done at home.
Overall, evidence suggests that the approach used in this study, which includes peer outreach and education, is safe for participants. No reports indicate negative effects from participating in similar outreach programs.12345Why are researchers excited about this trial?
Researchers are excited about the "Social Network Encouragement for Colon Cancer Screening" trial because it explores a novel way to boost colon cancer screening rates through peer support and education. Unlike traditional methods that rely solely on direct patient outreach and medical recommendations, this trial leverages social networks to encourage individuals to get screened. By providing both colorectal cancer education and peer outreach tools, like handouts and text messages, this approach aims to create a community-driven movement for increased screening. This method could potentially improve screening rates by harnessing the power of personal relationships and social influence, which is a fresh and promising strategy in the fight against colon cancer.
What evidence suggests that this trial's peer outreach intervention could be effective for increasing colorectal cancer screening?
Research shows that peer outreach can significantly increase colorectal cancer screening rates. In this trial, participants in the "FITx3 intervention and CRC education" arm will receive education and support to promote peer outreach, which studies have shown leads to a 42% increase in cancer screenings for underserved groups, including colorectal cancer. One study discovered that mailing information and offering patient support improved screening rates by 7.3 percentage points compared to regular care. These programs educate communities and provide necessary resources. Encouraging people to share information with friends and family has also yielded promising results in boosting screenings. Meanwhile, participants in the "Colorectal Cancer (CRC) education alone" arm will receive education on CRC and screening methods.12678
Who Is on the Research Team?
Francesca Gany, MD, MPH
Principal Investigator
Memorial Sloan Kettering Cancer Center
Are You a Good Fit for This Trial?
This trial is for Black men, aged 45-75, who have completed FIT testing in the past year. Participants must speak English or French fluently and have at least five close male peers over 45 years old. Men with a household member already in the study cannot join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Education and Training
Participants receive education on colorectal cancer and training on peer outreach to encourage FIT testing
Follow-up
Participants complete follow-up form and assist in completion of peer outreach tracker
What Are the Treatments Tested in This Trial?
Interventions
- Peer Outreach
Find a Clinic Near You
Who Is Running the Clinical Trial?
Memorial Sloan Kettering Cancer Center
Lead Sponsor
CANCER PREVENTION FUND
Collaborator